Lung Function

Among patients previously hospitalized with COVID-19, researchers estimated that up to 11% had fibrotic patterning, according to a study published in American Journal of Respiratory and Critical Care Medicine.

Marcus A. Mall, MD, whose work led to the development of the first triple therapy for patients with cystic fibrosis, won the Falling Walls Foundation’s Science Breakthrough of the Year in Life Sciences award, according to a press release.

In patients with nonvalvular atrial fibrillation receiving oral anticoagulants, factor Xa inhibitors appeared associated with increased risk for interstitial lung disease, according to a study published in JAMA Network Open.

With advanced X-rays and blood biomarkers, researchers have found how lung tissue scarring in patients with COVID and pulmonary fibrosis forms a distinctive form of fibrotic interstitial lung disease, according to a study in eBioMedicine.

A higher bacterial and fungal lung microbiota burden in patients with COVID-19 was linked to nonresolving acute respiratory distress syndrome, according to a study published in American Journal of Respiratory and Critical Care Medicine.

Researchers found a 25% increased risk for COPD among U.S. military veterans who took part in duties that had moderate or high likelihoods of exposure to inorganic dust, according to a research letter published in Chest.

Use of an oscillatory positive expiratory pressure device alone or with additional airway clearance improved lung function among children with cystic fibrosis, according to data presented at the North American Cystic Fibrosis Conference.

In children exposed to tuberculosis, chest radiography helped in detecting asymptomatic coprevalent TB and predicting incident TB after baseline, according to a study in American Journal of Respiratory and Critical Care Medicine.

Women with cystic fibrosis may experience declines in lung function after having been pregnant, according to a poster presented at the North American Cystic Fibrosis Conference.

Researchers observed a decline in lung function, measured by FEV1, among those who were exposed to gases, dusts, fumes and aromatic solvents at work, according to a study published in Occupational & Environmental Medicine.